These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Identification of Diphenoxylate as an Antiviral Agent Against Severe Acute Respiratory Syndrome Coronavirus 2
preprintsubmitted on 17.06.2020, 06:35 and posted on 19.06.2020, 06:44 by Jin Soo Shin, Eunhye Jung, Yejin Jang, Soo Bong Han, Meehyein Kim
This is the first report to show that diphenoxylate is highly active against SARS-CoV-2 with EC50 of 1.4 μM, CC50 over 100 μM and selectivity index over 71.4 after screening of 14 diphenyl derivatives. Our results with highly purified solid diphenoxylate confirmatively demonstrate that the viral S protein is reduced in the virus-infected cells in a dose-dependent manner. It could provide insights for antiviral treatment of COVID-19 with diphenoxylate or its chemical derivatives